Krystal Biotech’s (KRYS) “Buy” Rating Reaffirmed at HC Wainwright
HC Wainwright reissued their buy rating on shares of Krystal Biotech (NASDAQ:KRYS – Free Report) in a research note published on Wednesday morning,Benzinga reports. They currently have a $221.00 target price on the stock. A number of other equities research analysts have also weighed in on the stock. Citigroup boosted their target price on shares […]
HC Wainwright reissued their buy rating on shares of Krystal Biotech (NASDAQ:KRYS – Free Report) in a research note published on Wednesday morning,Benzinga reports. They currently have a $221.00 target price on the stock. A number of other equities research analysts have also weighed in on the stock. Citigroup boosted their target price on shares […]
